All Articles

The landmark partnership validates China's biotech prowess and injects Takeda's pipeline with next-gen cancer therapies, signaling a major industry shift.

With new funding, Japan's Helical Fusion is racing to build a fusion plant by the 2030s. Can its unique stellarator technology win the clean energy race?

With a high-grade Alaskan asset secured and a $44M war chest, Vizsla Copper is making a bold move in the race for North American resource security.

Fresh off its investment-grade rating, the LatAm giant's oversubscribed bond issue signals a major power play. Here's how it plans to win the future.

An inaugural award honors a top teacher, but it's the tech behind it—iCivics—that's tackling America's civic literacy crisis ahead of its 250th birthday.

How has a family-owned flooring store thrived for 55 years against big-box rivals? Mercury Carpet's story is a masterclass in quality and trust.

SoFi's surprise $1.5 billion stock sale sends shares tumbling. Is this a bold play for market dominance or a sign of fintech's increasing capital hunger?

For the seventh year, Aptar is named a top responsible company. Beyond the award, this is a look at how sustained ESG strategy creates a powerful competitive advantage.

A new federal investment aims to tackle the hidden crisis of violence against disabled women by scaling a support model built on shared experience.

In a complex financial market, one firm's new L&D chief isn't just a hire; it's a strategic weapon. Here's why their investment in talent could pay dividends.

A groundbreaking Miami Art Week event unites fashion, poetry, and design to redefine Indian creativity, moving beyond stereotypes to forge a new legacy.

A new fintech and education alliance aims to arm underserved founders with capital and skills, potentially unlocking the next wave of healthcare innovation.

Sachem Capital's dividend announcement reveals a ~19% yield. We dissect the strategy of this mortgage REIT and its role as a disruptor in private lending.

With a clear FDA path for its breakthrough drug, Praxis is set to disrupt the stagnant, multi-billion-dollar essential tremor market.

Beyond marble floors, the new luxury is a seamless, secure, and AI-driven transaction. We explore how tech is reshaping high-end property deals.

A Nasdaq firm is using AI real estate software profits to build a massive Solana treasury. Capital Currents unpacks DFDV's radical dual-pronged strategy.

Baxter is buying back billions in debt, a strategic move to clean its balance sheet. But with operational issues mounting, is it enough to win back investors?

After its DMD drug trial sent shares soaring over 370%, Capricor Therapeutics is raising $75M. A look at the high-stakes strategy to fund a breakthrough.

A new partnership seeks to launch a 50-branch roofing giant in one year, betting on a single software platform to conquer a fragmented, low-tech industry.

Immunome is using strategic stock grants to lure top talent. We analyze why this move is critical for its pipeline and what it means for investors.